Enhancing paracellular permeability by modulating epithelial tight junctions

Pharmaceutical Science and Technology Today

Volumn 3, Issue 10, 2000, Pages 346-358

  Ward, Peter D ^a   Tippin, Tim K ^b,c   Thakker, Dhiren R ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CELL MEMBRANE; CELL TYPE; CHELATION; CYTOSKELETON; DRUG ABSORPTION; DRUG PENETRATION; EPITHELIUM; HUMAN; HYDROPHILICITY; INTESTINE EPITHELIUM; MEDICAL RESEARCH; NONHUMAN; PERMEABILITY; REVIEW; TIGHT JUNCTION;

EID: 0034306505     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(00)00302-3     Document Type: Review

References (99)

1. The epithelial junction; bridge, gate, and fence
2. Regulation of tight-junction permeability during nutrient absorption across the intestinal epithelium
3. Enhanced bioavailability of cefoxitin using palmitoylcarnitine, II. Use of directly compressed tablet formulations in the rat and dog
4. Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships; an overview
5. +-dependent transepithelial transport of cephalosporins in Caco-2 cells
6. A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures
7. In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa
8. Tight junctions and the molecular basis for regulation of paracellular permeability
9. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelia permeability
10. Transport and permeability properties of human Caco-2 cells; an in vitro model of the intestinal epithelial cell barrier
11. In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine
12. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers
13. Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphospho-cholines across Caco-2 cell monolayers
14. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption; advantages and limitations of the Caco-2 model
15. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers; assessment by confocal laser scanning microscopy
16. 2+ in cultured epithelia
17. Route of passive ion permeation in epithelia
18. A conditionally immortalized epithelial cell line for studies of intestinal drug transport
19. Structure and permeability of goblet cell tight junctions in rat small intestine
20. A drug absorption model based on the mucus layer producing human intestinal goblet cell line HT29-H
21. Epithelial transport of drugs in cell culture, VII; effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells
22. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium; in vitro-in vivo correlation with permeability data from rats and humans
23. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria
24. Membrane asymmetry in epithelia; is the tight junction a barrier to diffusion in the plasma membrane?
25. The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells
26. Uncoupling of the molecular 'fence' and paracellular 'gate' functions in epithelial tight junctions
27. Occludin; a novel integral membrane protein localizing at tight junctions
28. Interspecies diversity of the occludin sequence; cDNA cloning of human, mouse, dog and rat-kangaroo homologues
29. Mammalian occludin in epithelial cells; its expression and subcellular distribution
30. A dominant mutant of occludin disrupts tight junction structure and function
31. Occludin-deficient embryonic stem cells; can differentiate into polarized epithelial cells bearing tight junctions
32. Connexin-occludin chimeras containing the ZO-binding domain of occludin localize at MDCK tight junctions and NRK cell contacts
33. Protein interactions at the tight junction
34. Claudin-1 and-2; novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin
35. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands
36. Occludin and claudins in tight-junction strands; leading or supporting players?
37. Manner of interaction of heterogeneous claudin species within and between tight junction strands
38. A single gene product, claudin-1 or-2, reconstitutes tight junction strands and recruits occludin in fibroblasts
39. Identification of ZO-1; a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia
40. Direct association between occludin and ZO-1 and its possible involvement in the localization of occludin at tight junctions
41. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton
42. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1
43. Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein
44. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin
45. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat
46. Regulation of intestinal sugar transport
47. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation
48. Hormonal regulation of hepatocyte tight junctional permeability
49. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability
50. Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia
51. Overexpression of protein kinase C-δ increases tight junction permeability in LLC-PK1 epithelia
52. 2+; a protein kinase C effect
53. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells
54. Possible involvement of phosphorylation of occludin in tight junction formation
55. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins
56. The phosphorylation of occludin correlates with occludin localization and function at the tight junction
57. Evidence that tyrosine phosphorylation may increase tight junction permeability
58. Tight junction structure and ZO-1 content are identical in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance
59. Phosphorylation of the tight junction protein ZO-1 in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance
60. The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain
61. Interactions between actin filaments and between actin filaments and membranes in quick-frozen and deeply etched hair cells of the chick ear
62. Effect of cytochalasin D on occluding junctions of intestinal absorptive cells; further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity
63. Vasopressin and A23187 stimulate phosphorylation of myosin light chain-1 in isolated rat hepatocytes
64. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells
65. Assembly and sealing of tight junctions; possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin
66. Ethanol modulation of intestinal epithelial tight junction barrier
67. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells
68. PKC-dependent regulation of transepithelial resistance; roles of MLC and MLC kinase
69. Oxidant and conductance of cultured epithelial cell monolayers; inositol phospholipid hydrolysis
70. Synergistic effects of a calcium ionophore and activators of protein kinase C on epithelial paracellular permeability
71. Effect of reversible ATP depletion on tight-junction integrity in LLC-PK1 cells
72. Epithelial transport of drugs in cell culture, VIII; effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells
73. Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells
74. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
75. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers
76. Mechanisms of absorption enhancement and tight junction regulation
77. Chitosans as absorption enhancers for poorly absorbable drugs, 1; influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells
78. Chitosans as absorption enhancers for poorly absorbable drugs, 2; mechanism of absorption enhancement
79. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces; in vitro evaluation in intestinal epithelial cells (Caco-2)
80. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments; in vitro evaluation in intestinal epithelial cells (Caco-2)
81. Chitosan for enhanced intestinal permeability; prospects for derivatives soluble in neutral and basic environments
82. Chitosans as absorption enhancers of poorly absorbable drugs, 3; influence of mucus on absorption enhancement
83. Der p1 facilitates transepithelial allergen delivery by disruption of tight junctions
84. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands; evidence for direct involvement of claudins in tight junction barrier
85. The movement of solutes and cells across tight junctions
86. Increased intestinal permeability in patients with Crohn's disease and their relatives
87. Intestinal permeability
88. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate
89. Barrier function of epithelia
90. Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers
91. Fracture faces of zonulae occludentes from 'tight' and 'leaky' epithelia
92. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides
93. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate
94. Protein kinase C isoenzymes; divergence in signal transduction?
95. Protein kinase C isozymes and substrates
96. PKCu is a novel, atypical member of the protein kinase C family
97. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate; assessment of molecular weight dependence and demonstration of transport routes
98. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers
99. Paracellular diffusion in Caco-2 cell monolayers; effect of perturbation on the transport of hydrophilic compounds that vary in charge and size